List view / Grid view

Dr John Maher (Leucid Bio)



Next-generation CAR T cells

23 January 2023 | By

Here, Dr John Maher responds to questions about how to overcome the challenges associated with developing chimeric antigen receptor (CAR) T-cell therapy for solid tumours and how the work as Leucid Bio is making strides towards this goal.